Effectiveness of rivastigmine in Alzheimer's disease (multiple letters) [3]

British Medical Journal

Volumn 319, Issue 7210, 1999, Pages 640-642

  Bentham, P ^a   Gray, R ^a   Sellwood, E ^a   Raftery, J ^a   Rosler, M ^a   Selai, C E ^a   Trimble, M R ^a   Rossor, M N ^a   Harvey, R J ^a   Storosum, J G ^a   Van Zwieten Boot, B J ^a   Elferink, A J A ^a  

^a QUEEN ELIZABETH PSYCHIATRIC HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CHOLINESTERASE INHIBITOR; DONEPEZIL; RIVASTIGMINE;

AGED; ALZHEIMER DISEASE; CAREGIVER; CLINICAL TRIAL; COGNITION; DAILY LIFE ACTIVITY; DIARRHEA; DISEASE COURSE; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; LETTER; NAUSEA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; QUALITY OF LIFE; SEIZURE; TREATMENT OUTCOME; VOMITING; WEIGHT GAIN;

ALZHEIMER DISEASE; CARBAMATES; CHOLINESTERASE INHIBITORS; HUMANS; PHENYLCARBAMATES; TREATMENT OUTCOME;

EID: 0033523485     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)